Buy Like Buffett
Watchlist

Flagship explainer

How cbdMD, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$19.2M · 100%Cost of revenue$7.2M · 38%Gross profit$12M · 62%Operating income−$2.2M · −11%Income before tax−$2M · −11%Income tax$0 · 0%Net income−$2M · −11%As of 2025-09-30 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$19.2M100%
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
Cost of revenue$7.2M38%
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
$12M62%
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
−$2.2M−11%
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
Income before tax−$2M−11%
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
Income tax$00%
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
−$2M−11%
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
Source:
  • 10-K · FY 2025Filing detailsAccession 0001437749-25-038435 · filed Dec 19, 2025
· event Sep 30, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full cbdMD, Inc. analysis at Buy Like Buffett